A

aTyr Pharma Inc
D

ATYR

5.21000
USD
0.05
(0.97%)
Market Closed
Volume
95,389
EPS
-0
Div Yield
-
P/E
-7
Market Cap
463,713,112
OverviewSignalsIdeasNews
Related Instruments
XEMUSD
XEMUSD
-0.0009875
(-16.68%)
0.0049079 USD
AEM
AEM
-1.630
(-1.33%)
121.020 USD
ASX
ASX
-0.260
(-2.50%)
10.135 USD
GFI
GFI
0.045
(0.19%)
24.375 USD
H
HL
-0.16500
(-2.78%)
5.77000 USD
I
IAG
-0.03500
(-0.48%)
7.23500 USD
KGC
KGC
-0.050
(-0.32%)
15.480 USD
N
NEM
-0.020
(-0.03%)
58.245 USD
N
NGD
0.02000
(0.42%)
4.83500 USD
More

Title: aTyr Pharma Inc

Sector: Healthcare
Industry: Biotechnology
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause tofibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.